Browse and fill a basket without an account. You must sign in as a member before you can check out.
PTA11 – Strategies for improving document quality
Who it is for
This workshop is suggested for experienced medical writers, particularly those who are in a supervisory role, or who will soon be taking on that responsibility.
What it covers
Improving the process of document preparation is crucial for medical writers. Discussion will include mechanisms for enhancing quality and accountability, and for ensuring adequate time allowances. These are organisational issues around which a medical writing group can build policies aimed at ensuring a higher degree of accountability among those with whom they work and upon whose input they
depend. Quality measures established by authoritative standards, as well as those that may be developed internally, are explored. Suggestions for effective
management and departmental structure will also be provided.
Art has a background in neurophysiology and behavioural medicine. As an independent consultant, he specialises in regulatory strategy, Data Safety Monitoring Board management, medical writing, and bioethics. Art has held senior posts at a
number of companies including Schering-Plough/Merck, Hoffmann-LaRoche, TFS,
and Quintiles, and headed departments responsible for medical writing, publications, project management, and regulatory affairs. He also served as a Senior Research
Fellow with the Centre for Innovation in Regulatory Sciences (CIRS). Art has extensive teaching experience and has presented to professional organisations (e.g. EMWA, AMWA, DIA), and corporate and academic audiences, worldwide. He spent 2 years heading Clinical Operations for an eDC ‘dot.com’ company, and has been active in CDISC since its inception. He served as Chair of the Global Ethics and Regulatory Initiative (GERI) of the Alliance for Clinical Research Excellence and
Safety (ACRES). He is a Founding Member of the Global Alliance of Publication
Professionals (GAPP), a Past President of AMWA, and a Fellow of both AMWA and EMWA. Art served in a Senior Advisory capacity on the Budapest Working Group in developing the CORE Reference. He has a particular interest in bioethics in the
context of clinical studies, is an advisor to an IRB, and serves on a number of task forces focusing on improving the drug development process while protecting the rights and safety of clinical study participants.
Sign in to check out
You can browse and fill a basket without an account. Sign in here to complete checkout — you stay on this page.
Reset your password
We will email a reset link. This page stays open.
Booking is for EMWA members
You are signed in, but this account does not have an active membership. You can keep browsing. Join EMWA to book — we will not send you away automatically.
Registration fee first
The conference registration fee (€50) must be in your basket before any session can be added. It is one off and covers the opening session and the plenary.
Terms and conditions
Changes to registration
Changes may be made to workshop or seminar choices after booking (that is, a cancellation of one workshop or seminar choice and replacement by another), for an administrative fee of €27, plus any difference in price between the choice of workshops or seminars. Workshops, seminars and lunchtime sponsored sessions may be added to your original registration (subject to availability) at any time, without an administrative fee by contacting info@emwa.org. All changes are subject to availability.
Cancellation of attendance
If you wish to cancel your attendance at the conference, a refund, minus an administration fee of €162, will be made provided your cancellation is made in writing to EMWA head office before 20 October 2026. No refunds will be made after this date.
Payments
Invoices must be settled by bank transfer in Euro, or paid by card through Stripe. All fees are payable in advance. Full payment is due by 30 October 2026. If payment has not been received, EMWA reserves the right to request payment and cancel registration.